Archer CGP research assays now enable homologous recombination deficiency (HRD) assessment for identification of key biomarkers critical for cancer research CORALVILLE, Iowa — With a history of driving innovation and collaboration in next generation sequencing (NGS), Integrated DNA Technologies is expanding its Archer portfolio of comprehensive genomic profiling (CGP) solutions to include homologous recombination deficiency […]
Accomplished R&D Leader and CRISPR Tools Expert Joins VedaBio to Drive Platform Expansion and Industrialization SAN DIEGO — VedaBio, a biotechnology company leading a paradigm shift in molecular detection, today announced the appointment of G. Brett Robb, Ph.D., as Senior Scientific Director and Head of CRISPR Science. With over 16 years of experience in life […]
DKSH has formed an exclusive partnership with Hygiena®, a global leader in food safety and health diagnostics solutions. DKSH will leverage its market expansion services to enhance Hygiena’s presence in Cambodia, Laos and Myanmar. Camarillo, California – DKSH Business Unit Technology has announced a new, exclusive partnership with Hygiena, a prominent provider in rapid microbial detection, […]
Highly Accurate Long-Read Sequencing Data from Revio will Support Germany’s National Genome Initiative and Provide Data to the International Male Infertility Consortium MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with the University Hospital of Münster, to use long-read whole genome sequencing to significantly […]
Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or “the Company”), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth […]
Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applications Dublin, Ireland, and Cheshire, UK: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Medicines Discovery Catapult (‘MDC’), an independent, not-for-profit drug discovery innovation centre, have signed a non-exclusive commercial-use CRISPR license agreement. The partnership combines ERS’s CRISPR/Cas9 patent […]
SAN JOSE, Calif. — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip ND™ Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for monitoring antimicrobial resistance (AMR), supporting efforts to ensure environmental safety and sustainability. The flexible system covers a variety of configurations, […]
Royal Society Hosts BioAro’s UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine Education NEW YORK — BioAro successfully launched its presence in the UK at the Royal Society on August 29th, 2024. BioAro’s UK launch marks a significant step in the company’s mission to revolutionize precision medicine. Leveraging advanced AI-driven genomic analysis, […]
Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today launched the new generation of the SOPHiA DDM™ Platform. The new-gen SOPHiA DDM™ Platform offers a new architecture designed to more efficiently compute large amounts of data at-scale, while elevating customer experience with […]
Illumina announces global expansion plans in India. At the Illumina India Genomics Summit on Friday 30 August 2024, Illumina announced the establishment of a Global Capability Center in Bengaluru, India, as an investment to expand its technology workforce in support of a global customer base. India is on its way to becoming the world’s third […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
